Reid T - Search Results

1

Navigating the clinical development landscape for oncolytic viruses and other cancer therapeutics: no shortcuts on the road to approval.

Breitbach CJ, Reid T, Burke J, Bell JC, Kirn DH. Breitbach CJ, et al. Among authors: reid t. Cytokine Growth Factor Rev. 2010 Apr-Jun;21(2-3):85-9. doi: 10.1016/j.cytogfr.2010.02.001. Epub 2010 May 15. Cytokine Growth Factor Rev. 2010. PMID: 20472490 Review.

2

Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial.

Reid T, Galanis E, Abbruzzese J, Sze D, Andrews J, Romel L, Hatfield M, Rubin J, Kirn D. Reid T, et al. Gene Ther. 2001 Nov;8(21):1618-26. doi: 10.1038/sj.gt.3301512. Gene Ther. 2001. PMID: 11895000 Free PMC article. Clinical Trial.

3

Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints.

Reid T, Galanis E, Abbruzzese J, Sze D, Wein LM, Andrews J, Randlev B, Heise C, Uprichard M, Hatfield M, Rome L, Rubin J, Kirn D. Reid T, et al. Cancer Res. 2002 Nov 1;62(21):6070-9. Cancer Res. 2002. PMID: 12414631 Clinical Trial.

4

Intravascular adenoviral agents in cancer patients: lessons from clinical trials.

Reid T, Warren R, Kirn D. Reid T, et al. Cancer Gene Ther. 2002 Dec;9(12):979-86. doi: 10.1038/sj.cgt.7700539. Cancer Gene Ther. 2002. PMID: 12522437 Free PMC article. Review.

5

A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma.

Hecht JR, Bedford R, Abbruzzese JL, Lahoti S, Reid TR, Soetikno RM, Kirn DH, Freeman SM. Hecht JR, et al. Clin Cancer Res. 2003 Feb;9(2):555-61. Clin Cancer Res. 2003. PMID: 12576418 Clinical Trial.

6

A novel assay to assess primary human cancer infectibility by replication-selective oncolytic adenoviruses.

Wang Y, Thorne S, Hannock J, Francis J, Au T, Reid T, Lemoine N, Kirn D, Halldén G. Wang Y, et al. Among authors: reid t. Clin Cancer Res. 2005 Jan 1;11(1):351-60. Clin Cancer Res. 2005. PMID: 15671566

7

Minimal hepatic toxicity of Onyx-015: spatial restriction of coxsackie-adenoviral receptor in normal liver.

Au T, Thorne S, Korn WM, Sze D, Kirn D, Reid TR. Au T, et al. Among authors: reid tr. Cancer Gene Ther. 2007 Feb;14(2):139-50. doi: 10.1038/sj.cgt.7700988. Epub 2006 Dec 1. Cancer Gene Ther. 2007. PMID: 17139321 Free PMC article. Clinical Trial.

8

Oncolytic virotherapy for advanced liver tumours.

Chang JF, Chen PJ, Sze DY, Reid T, Bartlett D, Kirn DH, Liu TC. Chang JF, et al. Among authors: reid t. J Cell Mol Med. 2009 Jul;13(7):1238-47. doi: 10.1111/j.1582-4934.2008.00563.x. Epub 2008 Oct 23. J Cell Mol Med. 2009. PMID: 19175689 Free PMC article. Review.

9

Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer.

Heo J, Reid T, Ruo L, Breitbach CJ, Rose S, Bloomston M, Cho M, Lim HY, Chung HC, Kim CW, Burke J, Lencioni R, Hickman T, Moon A, Lee YS, Kim MK, Daneshmand M, Dubois K, Longpre L, Ngo M, Rooney C, Bell JC, Rhee BG, Patt R, Hwang TH, Kirn DH. Heo J, et al. Among authors: reid t. Nat Med. 2013 Mar;19(3):329-36. doi: 10.1038/nm.3089. Epub 2013 Feb 10. Nat Med. 2013. PMID: 23396206 Free PMC article. Clinical Trial.

10

Going viral: a review of replication-selective oncolytic adenoviruses.

Larson C, Oronsky B, Scicinski J, Fanger GR, Stirn M, Oronsky A, Reid TR. Larson C, et al. Oncotarget. 2015 Aug 21;6(24):19976-89. doi: 10.18632/oncotarget.5116. Oncotarget. 2015. PMID: 26280277 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

958 results

Search Page

Filters